Symposium: Overcoming Pitfalls in Moving Compounds From Preclinical Development to the Clinic: Examples From Bench to Bedside (CE)

Moderator(s)

• 

  Dennis Hu, PhD

  CEO
  Drug Hunter Inc.

Presentations:

• 9:00 AM – 9:30 AM ET

  Challenges in Development of a Small Peptide-Based Therapeutic Targeting CNS
  

  Speaker: Mikhail Lomonosov, PhD – Ovoca Bio
• 9:30 AM – 10:00 AM ET

  RP-6306: Preclinical Experiences Delivering a Bioavailable and Selective PKMYT1 Inhibitor
  

  Speaker: Robert Papp, MSc – Repare Therapeutics
• 10:00 AM – 10:30 AM ET

  Navigating the Pain Points in Discovery & Preclinical Development of NaV1.7 Inhibitors
  

  Speaker: Jeanine Ballard, M.S. – Merck & Co., Inc.